BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/27/2026 10:00:11 AM | Browse: 0 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Scientometrics |
| Article Title |
Integrating traditional Chinese medicine with pancreatic cancer organoids: Bibliometric insights and translational perspectives
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qing-Ze Chen, Xiang Chi, Jia-Hao Pan, Qi-Zhi Cheng, Yi-Jun Guo, Yi-Xuan Liu, Lu Yu and Wei-Ke Feng |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Ke Feng, Associate Professor, College of Medicine, Shandong University of Traditional Chinese Medicine, No. 4655 University Road, Changqing District University Science and Technology Park, Jinan 250355, Shandong Province, China. fengweike315@163.com |
| Key Words |
Pancreatic ductal adenocarcinoma; Patient-derived organoids; Traditional Chinese medicine; Bibliometric analysis; Drug screening; Natural compounds; Precision oncology; Tumor microenvironment |
| Core Tip |
Pancreatic cancer is difficult to treat. Recently, scientists have started using organoids as a tool for testing new cancer drugs. Natural compounds from traditional Chinese medicine show potential because they can attack cancer cells in multiple ways. We analyzed > 1000 scientific papers to determine if researchers are using these advanced three-dimensional models to test traditional medicines. There was little research combining these two promising fields. By revealing this gap, we aim to encourage the scientific community to use patient-specific tumor models to evaluate natural medicines. This integration could accelerate the discovery of new, personalized treatments for pancreatic cancer, bridging the gap between natural remedies and modern precision medicine. |
| Citation |
Chen QZ, Chi X, Pan JH, Cheng QZ, Guo YJ, Liu YX, Yu L, Feng WK. Integrating traditional Chinese medicine with pancreatic cancer organoids: Bibliometric insights and translational perspectives. World J Gastrointest Oncol 2026; In press
|
 |
Received |
|
2026-06-02 10:09 |
|
Peer-Review Started |
|
2026-06-02 10:09 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-06-29 02:41 |
|
Revised |
|
2026-07-07 17:01 |
|
Publication Fee Transferred |
|
2026-07-16 08:06 |
|
Second Decision by Editor |
|
2026-07-27 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-07-27 10:00 |
|
Articles in Press |
|
2026-07-27 10:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
